Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Coating Systems & Additives
Thickeners and Stabilizers
Granulation
Taste Masking
Direct Compression
Chewable & Orodispersible Aids
Fillers, Diluents & Binders
Controlled & Modified Release
Co-Processed Excipients
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
26
PharmaCompass offers a list of Potassium Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Potassium Acetate manufacturer or Potassium Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Potassium Acetate manufacturer or Potassium Acetate supplier.
A CH3CO2K manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CH3CO2K, including repackagers and relabelers. The FDA regulates CH3CO2K manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CH3CO2K API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CH3CO2K manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A CH3CO2K supplier is an individual or a company that provides CH3CO2K active pharmaceutical ingredient (API) or CH3CO2K finished formulations upon request. The CH3CO2K suppliers may include CH3CO2K API manufacturers, exporters, distributors and traders.
click here to find a list of CH3CO2K suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A CH3CO2K DMF (Drug Master File) is a document detailing the whole manufacturing process of CH3CO2K active pharmaceutical ingredient (API) in detail. Different forms of CH3CO2K DMFs exist exist since differing nations have different regulations, such as CH3CO2K USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CH3CO2K DMF submitted to regulatory agencies in the US is known as a USDMF. CH3CO2K USDMF includes data on CH3CO2K's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CH3CO2K USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CH3CO2K suppliers with USDMF on PharmaCompass.
A CH3CO2K CEP of the European Pharmacopoeia monograph is often referred to as a CH3CO2K Certificate of Suitability (COS). The purpose of a CH3CO2K CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CH3CO2K EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CH3CO2K to their clients by showing that a CH3CO2K CEP has been issued for it. The manufacturer submits a CH3CO2K CEP (COS) as part of the market authorization procedure, and it takes on the role of a CH3CO2K CEP holder for the record. Additionally, the data presented in the CH3CO2K CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CH3CO2K DMF.
A CH3CO2K CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CH3CO2K CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CH3CO2K suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CH3CO2K as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CH3CO2K API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CH3CO2K as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CH3CO2K and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CH3CO2K NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CH3CO2K suppliers with NDC on PharmaCompass.
CH3CO2K Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CH3CO2K GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right CH3CO2K GMP manufacturer or CH3CO2K GMP API supplier for your needs.
A CH3CO2K CoA (Certificate of Analysis) is a formal document that attests to CH3CO2K's compliance with CH3CO2K specifications and serves as a tool for batch-level quality control.
CH3CO2K CoA mostly includes findings from lab analyses of a specific batch. For each CH3CO2K CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CH3CO2K may be tested according to a variety of international standards, such as European Pharmacopoeia (CH3CO2K EP), CH3CO2K JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CH3CO2K USP).
